|
A Novel Adjunctive LAT-Activating CART (ALA-CART) Cell Platform for the Treatment of Acute Leukemia |
University of Colorado Denver_ Anschutz Medical Campus |
Northwestern Mutual Foundation |
|
Creating an Infrastructure for Collaborative Clinical Research and Publication of Consensus Guidelines for RUNX1 Familial Platelet Disorder |
The Cleveland Clinic Foundation |
The RUNX1 Research Program |
|
Mutagenesis and disease progression in RUNX1 mutant blood stem cells is caused by inflammation-induced hyperactive signaling and supraphysiological mitochondrial ROS |
St. Jude Children’s Research Hospital |
The RUNX1 Research Program |
|
Investigating the Role of the MYCN Oncogene in Regulating Chemokine Expression in Neuroblastoma |
Children’s Hospital of Philadelphia |
Northwestern Mutual Foundation |
|
Structural rearrangement signatures as novel biomarkers for homologous recombination deficiency in cancer
|
Dana-Farber Cancer Institute |
Northwestern Mutual Foundation |
|
FGFR1 alterations in pediatric gliomas
|
Dana-Farber Cancer Institute |
Northwestern Mutual Foundation |
|
Synthetic Gene Expression Regulatory Switch engineered CAR T cells for children with cancer
|
Baylor College of Medicine |
Northwestern Mutual Foundation |
|
Identification and characterization of non-P53 stress pathways in Shwachman-Diamond syndrome |
The Cleveland Clinic Foundation |
Northwestern Mutual Foundation |
|
Understanding the association between genetic polymorphisms and adverse events during therapy for acute lymphoblastic leukemia
|
Emory University |
Northwestern Mutual Foundation |
|
Neuronal Regulation of Pediatric Brain Tumor Growth
|
Washington University |
Northwestern Mutual Foundation |
